Article

The interactions between cigarette smoking and reduced lung function on systemic inflammation

James Hogg iCAPTURE Center for Cardiovascular and Pulmonary Research, St. Paul's Hospital, Room No. 368A, 1081 Burrard St, Vancouver, BC, V6Z 1Y6 Canada.
Chest (Impact Factor: 7.48). 02/2005; 127(2):558-64. DOI: 10.1378/chest.127.2.558
Source: PubMed

ABSTRACT

Low-grade systemic inflammation is commonly observed in conditions associated with reduced FEV(1). Active cigarette smoking, which is a leading risk factor for decreased FEV(1), can also independently induce systemic inflammation.
To determine the independent contributions of active cigarette smoking and reduced FEV(1) (as well as their potential interactions) on systemic inflammation.
Cross-sectional survey.
The US general population.
A total of 7,685 adult participants, >/= 40 years of age, in the Third National Health and Nutrition Examination Survey, who had acceptable data on spirometry and laboratory measurements such as serum C-reactive protein (CRP).
The participants were stratified into four equal groups (quartiles) based on the percent predicted FEV(1) values. Each group was further categorized as active smokers or nonsmokers according to serum cotinine level (ie, >/= 10 or < 10 ng/mL). Serum levels of CRP, plasma fibrinogen, blood leukocytes, and platelets were compared across the predicted FEV(1) quartile groups and across smoking status using multiple logistic regression models.
We found that active smoking by itself increased the odds of having elevated CRP levels by 63% (adjusted odds ratio [OR], 1.63; 95% confidence interval, 1.28 to 2.09). The adjusted OR for reduced FEV(1) was 2.27 (95% confidence interval, 1.92 to 2.70). Having both risk factors increased the OR to 3.31 (95% confidence interval, 2.73 to 4.02). Similar findings were observed for blood leukocytes and plasma fibrinogen.
These findings suggest an additive effect of active smoking and reduced FEV(1) on markers of systemic inflammation and suggest their potential interactions in the pathogenesis of systemic complications observed in patients with poor lung function.

Download full-text

Full-text

Available from: Wen Qi Gan, Dec 13, 2013
  • Source
    • "Cigarette smoking is associated with an additive effect on inflammation, increasing levels of CRP, blood leukocytes and plasma fibrinogen [125]. Neutrophils and macrophages secrete IL-6, IL-1β, and TNF-α, inducing inflammation and regulation of CRP by these cytokines. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Several biological systems are implicated in the neuroprogression of bipolar disorder including but not limited to cytokine levels, oxidative stress markers, monoamine levels, tryptophan catabolite and glutamate-mediated excitotoxicity, microglial activation as well as structural and functional changes. The high rate of smoking behaviour in individuals with bipolar disorder provides the impetus for exploring shared and discrete pathogenetic mechanisms. In addition to contributing to increased mortality, smoking activates several neurobiological effector systems implicated in the progression of bipolar disorder. Here, a narrative review provides evidence and putative mechanisms of comorbid effects of BD, cigarette use, and nicotine dependence, and discusses the clinical implications of these interactions.
    Full-text · Article · Jan 2016 · Current Molecular Medicine
  • Source
    • "The reason our study did not show this association could be that our patients presented a mild anxiety and depression. As perioperative CRP and Fibrinogen might be affected by many factors, we examined whether inflammatory markers 1 month after surgery was different in group of patients considered at increased risk for higher levels of inflammation compared with lower risk ones (Table 4) [7,22,25,26,303132 . With the exception of video-assisted thoracoscopic surgery, no significant differences in fibrinogen or CRP were noted in other subgroups of patients. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Background: Major thoracic surgery is characterized by release of inflammatory markers.The objective of this study was to assess the preoperative and postoperative systemic inflammatory markers of patients undergoing lung cancer resection. Methods: This is a prospective follow up study conducted with 48 patients submitted to lung cancer resection.All patients were assessed before and 1 month after surgery through measurement of fibrinogen and C-reative protein(CRP), pulmonary function tests, 6- minute Walk Test (6MWT), maximal inspiratory pressure (PImax) and maximal expiratory preasure (PEmax), anxiety and depression scale and karnofsky performance status scale. Results: Both fibrinogen and CRP were higher 1 month after surgery, although only the change in CRP was statistically significant (p= 0.03). The following functional parameters: 6MWT, PImax, PEmax, FEV1(%) and FVC(%) decreased after surgery with p≤ 0.001 for all the parameters. Anxiety and depression improved and Karnofsky decrease after surgery (p= 0.03, p= 0.01 and p= 0.02; respectively). Change in CRP score following lung resection correlated significantly with changes in fibrinogen (r= 0.40; p= 0.003), change in Karnofsky scale (r= -0.50; p< 0.001) and a borderline significant trend with the 6MWT (r= -0.28; p= 0.05). With the exception of video-assisted thoracoscopic surgery (VATS), who had a significantly lower fibrinogen level 1 month after surgery compared with thoracotomy (p= 0.01), no significant differences in fibrinogen or CRP were noted in other subgroups of patients considered at increased risk for higher levels of inflammation compared with lower risk counterparts. Conclusion: Lung cancer resection surgery was associated with increased level of CRP, 1 month after surgery, and correlated directly with change in fibrinogen and inversely with measurement of performance status. VATS provided lower level of fibrinogen after surgery.
    Full-text · Article · Oct 2015 · Cancer biomarkers: section A of Disease markers
  • Source
    • "Data collected in the Third National Health and Nutrition Examination Survey (NHANES III) also found associations between increased CRP level and reduced pulmonary function [Cirillo et al., 2002; Mannino et al., 2003; Gan et al., 2005]. Moreover, when Gan et al. [2005] focused on smoking status, the authors observed an additive effect of current smoking on the inverse relationship of CRP, FEV 1 observed previously in this cohort. "
    [Show abstract] [Hide abstract]
    ABSTRACT: To assess the association between markers of systemic inflammation and pulmonary function in a population of structural firefighters. We studied male career members of a large Midwestern fire department with questionnaires, spirometry, and high-sensitivity C-reactive protein (hsCRP) as a biomarker of systemic inflammation. We examined percent predicted forced expiratory volume in 1 s (FEV1 %-predicted) and forced vital capacity (FVC%-predicted). Complete data were available for 401 firefighters. Higher hsCRP levels were associated with lower lung function values, after adjusting for confounding variables. Specifically, for every twofold increase in log10-hsCRP, FEV1 %-predicted decreased by a mean 1.5% (95% CI: 0.4, 2.6%) and FVC%-predicted decreased by a mean 1.4% (95% CI: 0.4, 2.3%). hsCRP as a biomarker of systemic inflammation may indicate reduced lung function in structural firefighters. Am. J. Ind. Med. © 2013 Wiley Periodicals, Inc.
    Full-text · Article · Jan 2014 · American Journal of Industrial Medicine
Show more